Bayer Stock
Bayer Stock
Bayer stock performed very well in the third quarter of 2006. The price of the company’s shares rose by 13.9 percent between the beginning of the year and the end of September. The closing price of €40.20 on September 30, 2006 not only represented the high for the first nine months of this year, it was also the highest level Bayer stock had reached in the past five years. Including the dividend of €0.95 per share for 2005, Bayer stock achieved a performance of 16.9 percent in the first nine months of 2006. Over the same period, the DAX rose by 11.0 percent to 6,004.
| Bayer Stock Key Data | ||||
| 3rd Quarter 2005 | 3rd Quarter 2006 | First Nine Months 2005 | First Nine Months 2006 | |
| High for the period (€) | 30.84 | 40.20 | 30.84 | 40.20 |
| Low for the period (€) | 26.78 | 35.32 | 22.02 | 30.56 |
| Average daily share turnover on German stock exchanges (million) | 3.9 | 5.1 | 4.3 | 6.0 |
| Sept. 30, 2005 | Sept. 30, 2006 | Dec. 31, 2005 | Change Sept. 30, 2006/ Dec. 31, 2005 % | |
| Share price (€) | 30.49 | 40.20 | 35.29 | 13.9 |
| Market capitalization (€ million) | 22,268 | 30,727 | 25,774 | 19.2 |
| Stockholders’ equity (€ million) | 11,088 | 13,164 | 11,157 | 18.0 |
| Number of shares entitled to the dividend (million) | 730.34 | 764.34 | 730.34 | 4.7 |
| DAX | 5,044 | 6,004 | 5,408 | 11.0 |
2005 figures restated
XETRA closing prices; source: Bloomberg
XETRA closing prices; source: Bloomberg
XETRA closing prices; Source: Bloomberg
The Capital Group Companies, Inc., U.S.A., has notified us pursuant to Section 21, Paragraph 1 of the German Securities Trading Act (WpHG) that the proportion of voting rights it holds in our company exceeded the 10 percent threshold on September 19, 2006, that since that date it has held 10.0179 percent of the voting rights and that all of these voting rights are attributable to it pursuant to Section 22, Paragraph 1, Sentence 1, No. 6 in conjunction with Section 22, Paragraph 1, Sentence 2 and Sentence 3 of the German Securities Trading Act. The Capital Research and Management Company, U.S.A., which according to our information is a subsidiary of The Capital Group Companies, Inc., also has notified us that the proportion of voting rights it holds in our company exceeded the 10 percent threshold on November 8, 2006, that since that date it has held 10.0852 percent of the voting rights and that all of these voting rights are attributable to it pursuant to Section 22, Paragraph 1, Sentence 1, No. 6 of the German Securities Trading Act.
Earnings per share according to IFRS are affected by the purchase price allocation (see Notes to the Interim Report ) and other special factors. To enhance comparability over time, we also determine core earnings per share (from continuing operations), from which these factors are excluded. We do this by eliminating from net income as per the income statement the amortization of intangible assets, asset write-downs (including any impairment losses), special items in EBITDA and extraordinary factors affecting income from investments in affiliated companies (such as divestment gains or write-downs), including the related tax effects. We also deduct income from discontinued operations.
Earnings per share according to IFRS are affected by the purchase price allocation (see Notes to the Interim Report ) and other special factors. To enhance comparability over time, we also determine core earnings per share (from continuing operations), from which these factors are excluded. We do this by eliminating from net income as per the income statement the amortization of intangible assets, asset write-downs (including any impairment losses), special items in EBITDA and extraordinary factors affecting income from investments in affiliated companies (such as divestment gains or write-downs), including the related tax effects. We also deduct income from discontinued operations.
| Calculation of Core Earnings per Share* | ||||
| 3rd Quarter 2005 | 3rd Quarter 2006 | First Nine Months 2005 | First Nine Months 2006 | |
| € million | ||||
| Net income | 493 | 320 | 1,551 | 1,372 |
| + Amortization and write-downs of intangible assets | 153 | 190 | 418 | 470 |
| + Write-downs of property, plant and equipment | 41 | 23 | 50 | 48 |
| +/- Special items (other than write-downs) | (170) | 335 | 74 | 497 |
| +/- Extraordinary income/loss from investments in affiliated companies | – | – | – | – |
| +/- Tax adjustment | (9) | (193) | (190) | (355) |
| +/- Income/loss from discontinued operations | (39) | (51) | (105) | (78) |
| Core net income from continuing operations | 469 | 624 | 1,798 | 1,954 |
| + Financing expenses for the mandatory convertible bond, net of tax effects | – | 25 | – | 48 |
| Adjusted core net income | 469 | 649 | 1,798 | 2,002 |
| Million shares | ||||
| Weighted average number of issued ordinary shares** | 730.34 | 760.28 | 730.34 | 740.43 |
| Potential shares to be issued upon conversion of the mandatory convertible bond | – | 60.12 | – | 41.30 |
| Adjusted weighted average total number of issued and potential ordinary shares | 730.34 | 820.40 | 730.34 | 781.73 |
| Core earnings per share from continuing operations (€) | 0.64 | 0.79 | 2.46 | 2.56 |
* Adjusted core net income and core earnings per share are not defined in the International Financial Reporting Standards. These indicators are therefore to be regarded only as supplementary information. The company believes that they give readers a clearer picture of the results of operations and ensure greater comparability of data over time.
** including newly issued shares from the capital increase pro rata temporis
** including newly issued shares from the capital increase pro rata temporis

Overview of Sales, Earnings and Financial Position
Bayer Links

Bookmark this page
E-mail this page
Advanced Search

